Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/26/2025

Management of Abnormal Rest/Stress SPECT Myocardial Perfusion Images

Initial Management Approach

  • The American Family Physician recommends a primary management approach for abnormal SPECT myocardial perfusion imaging, which is risk stratification based on the extent, severity, and location of ischemia, followed by intensification of medical therapy and selective referral to coronary angiography for high-risk features 1, 2, 3

High-Risk Features Requiring Invasive Evaluation

  • Patients with extensive stress-induced wall motion abnormalities should be referred for coronary angiography, as recommended by the American Heart Association, as published in Circulation 4
  • The American Heart Association, as published in Circulation, recommends referral for coronary angiography for patients with post-stress left ventricular ejection fraction (LVEF) ≤45% or reduction ≥5% from rest 4
  • Patients with transient ischemic left ventricular dilation should be referred for coronary angiography, according to the American Heart Association, as published in Circulation 4
  • Increased lung or right ventricular uptake is a high-risk marker that requires referral for coronary angiography, as recommended by the American Heart Association, as published in Circulation 4

Medical Management Pathway

  • The American Family Physician recommends intensifying guideline-directed medical therapy for patients without high-risk features, targeting morbidity and mortality reduction 1, 2
  • Initiation or optimization of antiplatelet therapy, statins, beta-blockers, and ACE inhibitors/ARBs is recommended by the American Family Physician 1
  • Aggressive risk factor modification, including diabetes control, hypertension management, and smoking cessation, is recommended, although the specific guideline society is not specified in this instance, it is generally in line with recommendations from groups like the American Heart Association 5

Special Considerations for Specific Populations

  • Consideration of PET imaging with myocardial flow reserve (MFR) quantification is recommended for patients with symptoms persisting despite absent perfusion defects, as suggested by Praxis Medical Insights, although the strength of evidence is not provided 5
  • An MFR <2.0 indicates microvascular dysfunction, even without visible perfusion defects, according to Praxis Medical Insights 5

Follow-Up Imaging Strategy

  • Repeat stress myocardial perfusion imaging is indicated in specific scenarios, including when symptoms change to redefine cardiac event risk, as recommended by the American Family Physician 1, 2, 3
  • The American Family Physician recommends repeat imaging at 3-5 years post-revascularization in high-risk asymptomatic patients, and at 1-3 years in patients with known CAD, stable symptoms, and predicted annual mortality >1% 1, 2

Critical Pitfalls to Avoid

  • Globally reduced perfusion should not be ignored, as it may represent balanced three-vessel or left main disease, according to the American Heart Association, as published in Circulation 4
  • Symptoms in patients with normal perfusion but reduced MFR should not be dismissed, as microvascular disease should be considered, especially in women, as suggested by Praxis Medical Insights 5
  • Delaying angiography in high-risk patients, such as those with SSS >13 or post-stress LVEF ≤45%, is not recommended due to significantly elevated mortality risk requiring revascularization evaluation, according to the American Heart Association, as published in Circulation 4

Guideline Summary: Interpretation of Stress‑Gated SPECT in Elderly Women

Perfusion Findings and Anatomical Correlation

  • A moderate‑to‑severe reversible perfusion defect involving the apical septal and anterior walls localizes to the left anterior descending (LAD) artery distribution, indicating a functionally significant stenosis in this vessel. 6
  • Homogeneous tracer uptake in the remaining myocardium suggests single‑vessel disease rather than multivessel involvement. 6
  • The reversibility of the defect (improved tracer uptake at rest) confirms myocardial ischemia rather than infarction, indicating that the affected myocardium remains viable. 7
  • The LAD supplies the largest myocardial territory; therefore, ischemia in this distribution is particularly concerning. 6

Diagnostic Accuracy of Gated Tc‑99m SPECT in Women

  • In women, gated Tc‑99m SPECT demonstrates 87 %–91 % sensitivity and 86 %–92 % specificity for detecting hemodynamically significant coronary stenoses. [8][9]
  • For moderate‑to‑severe perfusion abnormalities (summed stress score ≥ 8), the modality shows 91 % sensitivity for multivessel disease, although the perfusion pattern often points to isolated LAD disease. 8

Prognostic Implications

  • The presence of a perfusion defect of this magnitude raises the annual cardiac event rate markedly above the ≈1 % rate observed with normal studies. [8][9]
  • Women with such abnormal scans experience a decline in 3‑year survival from approximately 99 % (no ischemia) to 85 % (three‑vessel territory ischemia), mirroring the prognostic impact seen in men. 8

Age and Gender Considerations

  • Elderly women have a higher absolute risk of cardiac events compared with younger patients who exhibit similar perfusion abnormalities. [8][9]
  • Historically, women have been undertreated for coronary artery disease despite comparable or worse outcomes, underscoring the need for decisive management when SPECT findings are abnormal. [8][9]

Functional Assessment After Stress

  • A post‑stress ejection fraction of 78 % may reflect hyperdynamic compensation in non‑ischemic myocardial regions rather than reassurance of overall coronary health. 6
  • Breast attenuation artifacts commonly affect anterior and anterolateral walls; however, the observed reversible defects confirm true ischemia rather than artifact. [8][9]

REFERENCES

5

Assessing PET MPI for Microvascular Disease [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025